Back to search results

Real-WorlD ZolbetUximab in Patients With HER-2 Negative and CLaudin 18.2 PosItive MetastatiC AdEnocarcinoma

Abroad (travel likely)Recruiting

Conditions

Gastric Adenocarcinoma · Gastroesophageal Junction Adenocarcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • European Institute of Oncology, Milan, Italy

    Contact: Study coordinator (Nicola Fazio, MD,PhD) · divisione.gastrointestinale@ieo.it · 0257489258
    Contact: Principal Investigator (Nicola Fazio, MD,PhD)
    Chiara Alessandra Cella, MD (Sub-investigator)
    Lorenzo Gervaso, MD (Sub-investigator)
    Francesca Spada, MD (Sub-investigator)
    Lavinia Benini, MD (Sub-investigator)
    Davide Ciardiello, MD (Sub-investigator)
Study leads

  • Nicola Fazio, MD

    Study Director

    IEO

View source on ClinicalTrials.gov(opens in a new tab)